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Because activation of ERK1/2 MAP kinase
(MAPK) is critical for hippocampus-dependent
memory, there is considerable interest in mech-
anisms for regulation of MAPK during memory
formation. Here we report that MAPK and
CREB-mediated transcription are negatively
regulated by SCOP (suprachiasmatic nucleus
[SCN] circadian oscillatory protein) and that
SCOP is proteolyzed by calpain when hippo-
campal neurons are stimulated by brain-
derived neurotrophic factor (BDNF), KCl depo-
larization, or NMDA. Moreover, training for
novel object memory decreases SCOP in the
hippocampus. To determine if hippocampus-
dependent memory is influenced by SCOP in
vivo, we generated a transgenic mouse strain
for the inducible overexpression of SCOP in
the forebrain. Overexpression of SCOP com-
pletely blocked memory for novel objects. We
conclude that degradation of SCOP by calpain
contributes to activation of MAPK during
memory formation.
INTRODUCTION
MAP Kinase (MAPK) plays a critical role in several forms
of neuroplasticity including memory formation (for reviews
see Impey et al., 1999; Mazzucchelli and Brambilla, 2000;
Sweatt, 2004) and neuronal survival (for reviews see
Hetman and Xia, 2000; Heerssen and Segal, 2002). Acti-
vation of MAPK may be required for memory consolidation
because it mediates activity-dependent, Ca2+ stimulation
of cAMP response element (CRE)-mediated transcription
(Xing et al., 1996; Impey et al., 1998a; Athos et al., 2002)
and dendritic translation (Kelleher et al., 2004). For exam-
ple, MAPK is activated during training for hippocampus-
dependent memory (Athos et al., 2002; Atkins et al.,C1998; Blum et al., 1999; Sindreu et al., 2007) and by stim-
ulus paradigms that evoke long-term potentiation (LTP)
(English and Sweatt, 1996; Impey et al., 1998b). Inhibitors
of MAPK signaling block memory formation (Athos et al.,
2002; Atkins et al., 1998; Blum et al., 1999) and increases
in CRE-mediated transcription, which are required for
contextual memory (Athos et al., 2002; Atkins et al.,
1998; Blum et al., 1999). Gene-disruption studies also
support the hypothesis that MAPK activity is critical for
synaptic plasticity and memory. Disruption of the gene
for RasGRF, an activator of Ras, attenuates long-term
memory (LTM) for cued fear conditioning and LTP in the
basolateral amygdala (Brambilla et al., 1997). In addition,
disruption of the ERK1 gene has implicated MAPK-depen-
dent signaling in behavioral plasticity (Mazzucchelli et al.,
2002). Consequently, it is important to understand how
MAPK is activated in central nervous system (CNS) neu-
rons. Activity-induced increases in intracellular free Ca2+
can stimulate MAPK by several mechanisms including
calmodulin stimulation of RasGRF (Farnsworth et al.,
1995) or indirectly through stimulation of adenylyl cyclase
(Wang and Storm, 2003), subsequent activation of protein
kinase A (PKA), and stimulation of Rap1 (de Rooij et al.,
1998; Vossler et al., 1997).
Negative regulation of MAPK signaling may be just as
important for memory as stimulatory mechanisms. Mice
deficient in neurofibromatosis type 1, a RAS GTPase-acti-
vating protein, have defects in hippocampus-dependent
spatial memory, suggesting that a balance between Ras
stimulation and inhibition is critical for memory (Silva
et al., 1997). Recently, it was discovered that suprachias-
matic nucleus circadian oscillatory protein (SCOP) (Shi-
mizu et al., 1999) is a negative regulator of K-Ras in
PC12 cells (Shimizu et al., 2003). SCOP interacts directly
with K-Ras through its leucine-rich repeat and inhibits
K-Ras function by associating with the nucleotide-free
form of K-Ras. This prevents binding of GTP to K-Ras, in-
hibits its activity, and prevents neurotrophin stimulation of
MAPK. In PC12 cells, SCOP overexpression inhibits depo-
larization stimulation of MAPK by blocking K-Ras activity
(Shimizu et al., 2003). SCOP inhibition of K-Ras activity
is especially interesting because the K-Ras/MEK/MAPKell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc. 1219
pathway is critical for synaptic and behavioral plasticity
(Ohno et al., 2001).
Although SCOP attenuation of MAPK signaling has the
potential to play an important role in neuroplasticity, mech-
anisms for regulation of SCOP have not been reported.
Furthermore, it has not been established that SCOP regu-
lates MAPK/CRE-mediated transcription in CNS neurons,
a transcriptional pathway important for long-term memory
(Athos et al., 2002; Atkins et al., 1998; Blum et al., 1999;
Bourtchuladze et al., 1994; Pittenger et al., 2002) and neu-
ronal survival (Hetman et al., 1999; Mabuchi et al., 2001;
Watt et al., 2004). Here, we report that SCOP negatively
regulates CRE-mediated transcription in hippocampal
neurons and is rapidly degraded by calpain when neurons
are stimulated with brain-derived neurotrophic factor
(BDNF), NMDA, or KCl-induced depolarization. Interest-
ingly, SCOP is also rapidly degraded during training for
hippocampus-dependent memory, and SCOP-overex-
pressing transgenic mice have no long-term memory for
novel objects. These data suggest that SCOP constrains
MAPK activity and that its degradation contributes to the
transient activation of MAPK required for some forms of
hippocampus-dependent memory.
RESULTS
SCOP Expression in the Hippocampus
SCOP was originally discovered as a protein that un-
dergoes a circadian oscillation in the suprachiasmatic
nucleus (SCN) but not in other regions of brain (Shimizu
et al., 1999). To explore the role of SCOP in regulation of
MAPK signaling in the hippocampus, we examined its dis-
tribution in brain by immunohistochemistry (Figure 1A).
SCOP immunoreactivity was present predominantly in the
somata and processes extending from somata in area
CA1 of the rat and mouse hippocampus. SCOP is also ex-
pressed in area CA3 but not the dentate gyrus. The SCOP
immunostaining in the hippocampus was completely
blocked when the SCOP antibody was preabsorbed with
SCOP protein. Because of the importance of the hippo-
campus for memory formation, this study focused on the
regulatory role of SCOP in hippocampal neurons in vitro
and in vivo.
SCOP Inhibits CRE-Mediated Transcription
in Cultured Hippocampal Neurons
One of the major MAPK-activated transcriptional path-
ways implicated in hippocampus-dependent memory is
CRE-mediated transcription (Athos et al., 2002; Bourtchu-
ladze et al., 1994; Impey et al., 1998b; Xing et al., 1996). To
determine if SCOP inhibits stimulation of this transcrip-
tional pathway in hippocampal neurons, neurons were co-
transfected with a reporter for CRE-mediated transcrip-
tion with varying amounts of a SCOP expression vector
(Figure 1B). BDNF stimulation of CRE-mediated transcrip-
tion in hippocampal neurons was progressively inhibited
by increasing amounts of SCOP, with almost complete in-
hibition at the highest levels of SCOP. This indicates that1220 Cell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc.SCOP can function as a negative regulator of CRE-medi-
ated transcription in hippocampal neurons.
If endogenous SCOP inhibits MAPK and CRE-mediated
transcription, inhibition of SCOP expression should in-
crease CRE-mediated transcription. To test this, hippo-
campal neurons were cotransfected with SCOP siRNA,
Figure 1. CRE-Mediated Transcription in Hippocampal Neu-
rons Is Inhibited by SCOP
(A) SCOP immunoreactivity was detectable in several areas of the rat
and mouse hippocampus, including area CA1. Coronal sections of
the hippocampus were stained with SCOP antibody and visualized
using 3-30 diaminobenzidine as described in Experimental Procedures.
The diagrams on the right side identify those areas of the hippocampus
shown in the images. Scale bars represent 100 mm.
(B) SCOP overexpression inhibits BDNF stimulation of CRE-mediated
transcription. Cultured hippocampal neurons were cotransfected with
a CRE-luciferase reporter construct and varying amounts of a SCOP
expression plasmid or empty vector (total 300 ng). An expression
vector for b-galactosidase was cotransfected for normalization of
transfection efficiencies. Luciferase activity was measured 6 hr after
BDNF (5 ng/ml) or vehicle treatment. Data are reported as the percent
activity relative to the vector control. Error bars, standard error of the
mean (SEM) (n = 3).
(C) Inhibition of SCOP expression by siRNA stimulates CRE-mediated
transcription. Cultured hippocampal neurons were cotransfected with
a CRE-luciferase reporter construct with SCOP siRNA, or a scrambled
RNA of the same composition. Luciferase activity was measured 24 hr
after transfection and was normalized to b-galactosidase activity. Error
bars, SEM (n = 3).
or a scrambled RNA sequence of the same composition,
and a reporter for CRE-mediated transcription. In unsti-
mulated cells, SCOP siRNA increased CRE-mediated
transcription 4-fold, a stimulation twice that obtained
with BDNF alone (Figure 1C). These data indicate that en-
dogenous SCOP constrains CRE-mediated transcription
in hippocampal neurons. We confirmed that SCOP siRNA
attenuates MAPK activation using a lentivirus construct
to express the SCOP siRNA. Lentivirus expression of the
SCOP siRNA depressed SCOP protein and activated
pERK in unstimulated and BDNF-treated hippocampal
neurons (Figure S1).
Treatment of Hippocampal Neurons with BDNF,
NMDA, or KCl Decreases SCOP Protein
Because SCOP inhibits MAPK signaling and blocks stim-
ulation of CRE-mediated transcription, it was important
to determine how SCOP itself is regulated in hippocampal
neurons. Since we were unable to detect phosphorylation
of SCOP (data not shown), we considered the possibility
that SCOP may be degraded when neurons are stimulated
with BDNF or other activators of MAPK. We monitored
SCOP protein levels by western analysis after hippocam-
pal neurons were treated with BDNF. Within 5 min of
BDNF treatment, SCOP protein was reduced by 50%
compared to controls and returned to unstimulated levels
by 60 min (Figure 2A). We also found that depolarization
of cultured hippocampal neurons with KCl or treatment
with NMDA reduced SCOP levels 52% and 44%, respec-
tively (Figure 2B). Similar results were obtained when cul-
tured cortical neurons were treated with BDNF; SCOP
protein was rapidly degraded and returned to baseline
within 3 hr (data not shown). The fact that SCOP protein
was never totally degraded suggests that SCOP levels
may be maintained by a balance between protein synthe-
sis and proteolysis.
SCOP Is Proteolyzed by Calpain
The rapid reduction in SCOP protein when neurons are
treated with BDNF, KCl, or NMDA suggests that it may
be degraded by a protease. The fact that SCOP levels re-
turn to baseline relatively quickly suggest that transient
activation of a protease stimulates SCOP degradation.
We focused on Ca2+-stimulated proteases because acti-
vation of NMDA receptors (Dingledine, 1983), BDNF (Ber-
ninger et al., 1993; Li et al., 1998), and KCl depolarization
(Di Virgilio et al., 1987) all cause transient increases in
intracellular free Ca2+.
In cell-free, hippocampal extracts, SCOP was rapidly
degraded in the presence of free Ca2+ but not in its ab-
sence, suggesting that SCOP is susceptible to degrada-
tion by a Ca2+-activated protease (Figure 3A). To identify
the protease responsible for degradation of SCOP we
examined inhibitors of several proteases including cas-
pase-3 (Chan and Mattson, 1999; Dash et al., 2000), pro-
teasome (Cline, 2003; Hegde, 2004; Lopez-Salon et al.,
2001), and calpain (Chan and Mattson, 1999). These prote-
ases are present at synapses and have been implicated inCneural plasticity and memory formation (for reviews see
Cline, 2003; Chan and Mattson, 1999). Neither the cas-
pase-3 inhibitor nor lactacystin, a proteasome inhibitor,
blocked Ca2+-induced SCOP degradation (Figure 3B).
Only calpeptin inhibited SCOP degradation, indicating
that SCOP may be degraded by Ca2+-stimulated calpain.
We confirmed that calpain is activated when hippocampal
neurons are treated with BDNF (data not shown).
There are two major calpain isoforms, calpain I (m-form)
and calpain II (m-form), which are activated at different
Figure 2. BDNF Stimulates Rapid Degradation of SCOP in
Hippocampal Neurons
(A) SCOP protein in cultured hippocampal neurons (day 18 in vitro, DIV
18) was monitored by western analysis various times after treatment
with BDNF (50 ng/ml). The bar graph shows SCOP protein normalized
to ERK-2. Error bars, SEM (n= 3).
(B) SCOP protein in cultured hippocampal neurons (DIV 18) was mon-
itored by western analysis 10 min after treatment with KCl (50 mM) or
NMDA (50 mM). SCOP protein was normalized relative to ERK-2. Error
bars, SEM (n = 3).ell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc. 1221
Figure 3. Calpain Catalyzes the Proteoly-
sis of SCOP
(A) SCOP protein was monitored by western
analysis after adding Mg2+ (10 mM) and/or
Ca2+ (4 mM) to mouse brain lysates and incu-
bating for 3 hr at 4C.
(B) Calpeptin inhibited Ca2+-stimulated prote-
olysis of SCOP. The mouse brain extract was
pretreated with a caspase-3 inhibitor (10 mM),
lactacystin (5 mM), or calpeptin (10 mM) 30 min
before adding Ca2+. SCOP protein was moni-
tored by western analysis.
(C) Calpain I and II both catalyzed the proteoly-
sis of SCOP in vitro. Calpain I or II was incu-
bated with immunoprecipitated SCOP at 37C
for 1 hr. SCOP protein was monitored by west-
ern analysis.Ca2+concentrations. Within the brain, calpain I is predom-
inantly neuronal, existing at higher levels in the dendrites
and cell bodies, whereas relatively higher levels of calpain
II have been observed in axons and glia (Nixon, 1986;
Onizuka et al., 1995). To determine if SCOP is selectively
proteolyzed by calpain I or II, we incubated purified cal-
pain I and II with immunoprecipitated SCOP. Both cal-
pains degraded SCOP protein in vitro (Figure 3C).
To ascertain if calpain proteolyzes SCOP in hippocam-
pal neurons, we treated neurons with calpain inhibitor III
and monitored SCOP degradation when BDNF was ap-
plied (Figure 4A). The decrease in SCOP levels caused
by BDNF was completely blocked by calpain inhibitor III,
and furthermore there was a significant increase in SCOP
levels after treatment with the protease inhibitor. This sug-
gests that SCOP levels are controlled by a balance be-
tween synthesis of the protein and degradation by calpain.
This was confirmed by examining SCOP levels when hip-
pocampal neurons were treated with calpain inhibitor III,
without BDNF (Figure 4B). Endogenous SCOP protein
increases approximately 2-fold by 90 min after treatment
with the protease inhibitor. If SCOP negatively regulates
MAPK signaling and calpain degrades SCOP, proteolytic
degradation of SCOP may contribute to MAPK activation.
Indeed, stimulation of MAPK activity in hippocampal neu-
rons by BDNF was decreased at least 2-fold when calpain
activity was blocked (Figure 4C).
SCOP Degradation Following Training for Novel
Object Memory
Since activation of MAPK is required for object recognition
memory (Kelly et al., 2003), it was of considerable interest
to determine if the levels of SCOP protein decrease during
training for object recognition memory. We measured1222 Cell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc.SCOP 5 min after training for novel object recognition (Fig-
ure 5). In this paradigm, a mouse is allowed to briefly
examine two novel objects, A and B. When the mouse is
tested at a later time, it is presented with one of the original
objects, A, and a new object, C. If the mouse remembers
object A, it will spend more time examining object C be-
cause of natural curiosity for new objects. Memory for
novel objects is reflected by greater preference for the
new object C during testing (Figure 5A). We examined
SCOP levels following training for novel objects because
this is a milder form of training that does not depend on
shocking the animal. Untrained controls were handled
and placed in the training cage without novel objects. Al-
though the decrease in SCOP seen at 5 min after training
for novel objects was only 16%, it was significant (p < .01),
and was paralleled by an increase in MAPK activity
(p < .05) (Figure 5B). SCOP protein also decreased when
animals were trained for context (Figure S4). Presumably
changes in SCOP and MAPK activity are much greater
in neurons directly affected during training than that mea-
sured by western analysis of extracts from the entire
hippocampus.
Overexpression of SCOP in the Hippocampus Blocks
Memory for Novel Objects
To determine if hippocampus-dependent memory is sen-
sitive to the amount of SCOP expressed in the hippocam-
pus in vivo, we made a tetracycline-inducible, SCOP-
overexpressing mouse strain using the CamKIIa promoter
to limit overexpression to the forebrain. The integration of
transgene was verified by polymerase chain reaction
(PCR)-based genotyping using specific primers for tetra-
cycline response element-SCOP (TRE-SCOP) and Cam-
KII-rtTA2 transgene, respectively (Figure 6A). Doxycycline
Figure 4. Inhibition of Calpain in Cultured Hippocampal Neurons Blocks SCOP Degradation and Inhibits Activation of MAPK
(A) Calpain inhibitor III inhibited BDNF-induced SCOP degradation in cultured hippocampal neurons. Neurons were pretreated with calpain inhibitor III
(25 mM) or vehicle 30 min before BDNF (5 ng/ml) stimulation and harvested at various times. SCOP protein was monitored by western analysis. SCOP
protein was normalized to actin. Error bar, SEM (n=3).
(B) Treatment of hippocampal neurons with calpain inhibitor III increases SCOP. Neurons were pretreated with calpain inhibitor III (25mM) or vehicle
and harvested at various times after applying calpain inhibitor III (25 mM) or vehicle. SCOP was quantitated by western analysis. SCOP levels were
normalized to ERK-2.
(C) Calpain inhibitor III inhibits BDNF stimulation of MAPK activity measured as pERK in cultured hippocampal neurons. Total ERK-2 measured on the
same western blot was used as loading controls. The percentage change in pERK relative to the 0 time point is reported. Error bars, SEM (n = 3).treated TRE-SCOP 3 CamKll-rtTA2 mice showed 1.5-
to 2.5-fold higher SCOP in the hippocampus than those
not treated with doxycyline (Figure 6A, right panel of west-
ern blot and graph); doxycycline-treated TRE-SCOP or
CamKll-rtTA2 mice showed no increase in SCOP com-
pared to littermate controls. In control experiments, we
verified that doxycycline treatment did not affect the
memory of wild-type, TRE-SCOP, or CamKll-rtTA2 mice
for novel objects (data not shown). Overexpression of
SCOP did not alter open-field activity or contextual mem-
ory indicating that general mobility and vision were unaf-Cfected (data not shown). Doxycyline treatment of TRE-
SCOP 3 CamKll-rtTA2 mice, which increases SCOP in
the hippocampus, had no effect on memory for novel
objects measured 8 min after training (Figure 6B) but com-
pletely blocked memory for novel objects measured 24 hr
after training (Figure 6C). These data are consistent with
other experiments showing that MAPK activity is required
for memory consolidation but not acquisition or short-term
memory (Blum et al., 1999; Kelleher et al., 2004). We con-
firmed that overexpression of SCOP in the transgenic
mouse strain blocks decreases in SCOP protein and theell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc. 1223
increase in pERK associated with training for novel ob-
jects (Figure S2). When doxycyline-treated mice were
allowed to recover for 3 months, they exhibited normal
24 hr memory for novel objects (Figure 6D). Overexpres-
sion of SCOP did not completely block the increases in
pERK observed during training for context (Figure S5)
and did not block contextual memory. We conclude that
memory for novel objects is sensitive to the concentration
of SCOP in the hippocampus.
The data described above indicates that memory for
novel objects may depend on the levels of SCOP protein
in the hippocampus. If calpain degradation of SCOP con-
tributes to memory for novel objects, inhibition of calpain,
in vivo, should block memory. Indeed, when a mixture of
calpain inhibitors was bilaterally administered into area
CA1 of the hippocampus, memory for novel objects mea-
sured 24 hr after training was completely blocked with no
effect on short-term memory measured 8 min after training
(Figure 7). This indicates that calpain activity is required for
Figure 5. Training for Novel Object Memory Decreases SCOP
in the Hippocampus
(A) The time spent exploring two novel objects (A and B) was measured
for 5 min during training. Preference for one of the original objects (A)
and a new object (C) was quantified 24 hr after training. The dotted line
represents no object preference. Error bars, SEM (n = 8 mice).
(B) SCOP and pERK in the hippocampus from trained and untrained
mice were analyzed by western analysis 5 min after training. Untrained
mice were handled and placed in the training chamber without novel
objects. SCOP and p-ERK were normalized to ERK-2 from the western
blot. Error bars, SEM (n = 9).1224 Cell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc.novel object long-term memory, possibly because calpain
degrades SCOP in vivo. We confirmed that the decrease
in SCOP and increase in pERK observed 5 min after train-
ing for novel objects is blocked by infusion of calpain
inhibitors into area CA1 of the hippocampus (Figure S3).
DISCUSSION
SCOP was originally identified as a protein whose expres-
sion is regulated in a circadian manner within the SCN
(Shimizu et al., 1999). The discovery that SCOP inhibits
MAPK activity (Shimizu et al., 2003) provides an explana-
tion for the circadian oscillation of MAPK activity and CRE-
mediated transcription in the SCN (Obrietan et al., 1998).
The presence of SCOP in the hippocampus raised the in-
teresting possibility that it may inhibit MAPK in the hippo-
campus and play an important role in MAPK signaling
during memory formation and other MAPK-regulated
events. The objectives of this study were to determine if
SCOP regulates CRE-mediated transcription in hippo-
campal neurons and to identify mechanisms for signaling
through SCOP. Furthermore, it was important to deter-
mine if SCOP is regulated during training for hippocam-
pus-dependent memory in vivo and if varying the levels
of SCOP in vivo affects memory formation.
We discovered that SCOP inhibits CRE-mediated tran-
scription in hippocampal neurons and that treatment with
BDNF, KCl, or NMDA causes rapid degradation of SCOP
protein. The decrease in SCOP is dependent upon in-
creased intracellular Ca2+ and blocked by calpain inhibi-
tors, suggesting that activity-dependent increases in Ca2+
stimulate calpain, which degrades SCOP. When cultured
neurons are treated with calpain inhibitors, there is a con-
stant rise in SCOP protein suggesting that the levels of
SCOP reflect a balance between newly translated protein
and proteolysis. Furthermore, BDNF stimulation of MAPK
activity in hippocampus neurons is greatly reduced by
calpain inhibitors supporting the hypothesis that calpain-
stimulated degradation of SCOP is necessary for full acti-
vation of MAPK in neurons.
We believe that SCOP may regulate MAPK signaling
in vivo because SCOP decreased and MAPK activity in-
creased during training for novel objects or contextual
memory. The decrease in SCOP protein, stimulation of
MAPK, and memory for novel objects were completely
blocked by overexpressing SCOP in the hippocampus.
When SCOP was overexpressed, training for contextual
fear still gave a measurable decrease in SCOP protein
and an increase in MAPK activity. Since the MAPK activa-
tion is only partially blocked by SCOP overexpression dur-
ing contextual training, the mice still exhibit memory for
context. This suggests that the training stimulus during
contextual training is more robust and leads to greater re-
duction in SCOP levels. We hypothesize that proteolytic
degradation of SCOP releases a constraint on K-Ras ac-
tivity and contributes to MAPK activation (Figure 8). This
hypothesis is supported by data showing that memory
for novel objects depends on calpain activity (Figure 7).
Figure 6. Overexpression of SCOP in the
Hippocampus Blocks Long-Term but Not
Short-Term Memory for Novel Objects
(A) SCOP in the hippocampus of TRE-SCOP 3
CamKII-rtTA2 transgenic mice was increased
by feeding doxycycline (Dox). Upper panels
show the SCOP western blot for each mouse,
and the bar graphs reports SCOP normalized
to actin. Lower panels show the corresponding
PCR genotyping of the transgenic mice.
(B) Overexpression of SCOP (Dox) in the fore-
brain did not block short-term memory for
novel objects measured 8 min after training.
Error bars, SEM (no Dox, n = 8 mice; Dox,
n = 13).
(C) Overexpression of SCOP in the forebrain
blocked memory for novel objects measured
24 hr after training. Error bars, SEM (no Dox,
n = 12 mice; Dox, n = 22 mice).
(D) Doxycyline-treated mice were allowed to
recover for 3 months after removal of doxycy-
line, trained for novel objects, and tested
24 hr after training. Error bars, SEM (n = 8 mice).Our data does not exclude other mechanisms by which
calpain may contribute to activation of MAPK. Although
calpain-1 knockout mice show no apparent defects in
LTP or fear conditioning (Grammer et al., 2005), SCOP is
degraded by both calpain-1 and calpain-2. Consequently,
definition of the role of calpains in memory formation
through gene disruption may require conditional double
knockouts of calpain-1 and calpain-2.
Considering the general importance of MAPK for neuro-
plasticity, one would expect that its activity in CNS neu-
rons would be tightly regulated (for a review see Agell
et al., 2002). There are several mechanisms for activation
of MAPK by Ca2+ including direct activation through cal-
cium-stimulated Ras GEFs (Farnsworth et al., 1995) and
indirect mechanisms mediated through calcium-stimu-
lated adenylyl cyclases and PKA. We propose that in
unstimulated neurons, SCOP restrains MAPK activity
and that transient decreases in SCOP caused by Ca2+
stimulation of calpain is required for activation of MAPK
caused by neurotrophins and Ca2+ signals. Thus, activa-
tion of MAPK in neurons may depend upon a dynamic bal-
ance between SCOP degradation and MAPK-activating
mechanisms.CAlthough this study focused on regulation of SCOP in
hippocampal neurons and its relationship to memory
formation, the data have broad implications because of
the central role played by MAPK and CRE-mediated tran-
scription in neuroplasticity (Frankland et al., 2003; Impey
et al., 1999; Mazzucchelli and Brambilla, 2000; Sweatt,
2004). It seems likely that other in CNS neurons, including
synaptic plasticity (Coogan et al., 1999; English and
Sweatt, 1996), protein synthesis (Kelleher et al., 2004), cir-
cadian rhythm (Obrietan et al., 1999; Obrietan et al., 1998),
modulation of K+ ion channels (Yuan et al., 2002), and neu-
ronal survival (Hetman et al., 1999), may depend upon
SCOP protein and its regulated degradation. For example,
the circadian oscillation of SCOP protein in the SCN cor-
relates with the changes in MAPK activity during the circa-
dian cycle (Shimizu et al., 1999). The extent to which reg-
ulation of SCOP levels contribute to these processes
remains to be established.
In summary, maximal activation of MAPK activity in hip-
pocampal neurons depends on degradation of SCOP by
calpain. Training for novel object memory lowers SCOP
in brain, and memory for novel objects was blocked
when SCOP was increased 2-fold in the hippocampus.ell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc. 1225
We hypothesize that calpain-catalyzed degradation of
SCOP in response to activity-dependent Ca2+ increases
is required for activation of MAPK during formation of
hippocampus-dependent memory.
EXPERIMENTAL PROCEDURES
Cell Culture
Neurons were cultured as previously described with some modifica-
tions (Chan et al., 1998). Primary hippocampal neurons were cultured
from newborn C57BL6 pups and maintained in Neurobasal-A (GIBCO)
with minimal supplements. Pups were sacrificed by decapitation, and
the hippocampi were digested in 5 ml of 10 units/ml papain at 37C for
30 min. After two rinses, the tissue was triturated three times in disso-
ciation medium (27 mM K2SO4, 15 mM MgCl2, 74 mM Na2SO4, 18 mM
glucose, 225 mM CaCl2, 0.0012% phenol red and 2 mM HEPES, pH
7.4) using a 5 ml disposable plastic pipette. Cells were plated into
24-well plates or 3 cm dishes coated with poly-D-lysine (50 mg/ml) at
5 3 104 cells/cm2 in Neurobasal-A medium containing B-27 supple-
ment with 10 units/ml penicillin, 10 mg/ml streptomycin, 0.5 mg/ml
Figure 7. Inhibition of Calpain In Vivo Blocks Memory for
Novel Objects
A calpain Inhibitor cocktail containing a mixture of calpeptin, calpain
inhibitor I and calpain inhibitor III or vehicle was bilaterally infused in
area CA1 in the hippocampus. Mice were trained 45 min after infusion.
Object preference was measured 24 hr after training (A) or 8 min after
training (B). Error bars, SEM (n=10 (24 hr), n=8 (8 min) mice in each
group). The dotted line represents performance by chance 50%.1226 Cell 128, 1219–1229, March 23, 2007 ª2007 Elsevier Inc.glutamine, and 1% fetal bovine serum. The medium was changed to
Neurobasal-A with B-27 containing 0.5 mg/ml glutamine and 2 mM
AraC 24 hr after plating. Neurons were maintained in Neurobasal-A
with B-27 and 0.5 mg/ml glutamine, and half of the media was changed
every 2 days. Plates were incubated in a CO2 incubator at 37
C.
Preparation of siRNA
The siRNA targeted against SCOP mRNA was designed with a two-
base 30 overhang. The target site was nuceotides 292–312 from the
start codon (AACTCGCTGCTGCTGAGGAGA). The single-strand
siRNA nucleotides were chemically synthesized with dTdT 30 over-
hangs (CUCGCUGCUGCUGAGGAGAtt, UCUCCUCAGCAGCAGCGA
Gtt) (Ambion). A scrambled sequence of the same nucleotide compo-
sition as the SCOP siRNA with no significant sequence homology to
the genome was used as a negative control (UAUGCCGGCUGGA
GUACCGtt, CGGUACUCCAGCCGGCAUAtt). Complementary pairs
of siRNA oligonucleotides were annealed in annealing buffer (6 mM
HEPES, pH 7.4, 20 mM potassium acetate, 0.4 mM magnesium ace-
tate). The annealed double-stranded RNAs were confirmed by acryl-
amide electrophoresis. For transfection of neurons, 16 nM of siRNA
was used.
Expression Plasmids
The full-length SCOP overexpression plasmid and CRE (a168)-lucifer-
ase have been described previously (Matthews et al., 1994; Shimizu
et al., 2003).
Reporter Assays for CRE-Mediated Transcription
Cultured hippocampal neurons in 24-well plates at day 7 in vitro were
transfected with a complex of 0.15 mg of CRE-luciferase, 0.15 mg of the
internal control plasmid EF1a-lacZ, 0.3 mg of the described plasmid (in
each well of a 24-well plate), and Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s protocol. Twenty-four hours after trans-
fection, 5 ng/ml BDNF in 0.2% BSA or vehicle (0.2% BSA) was applied.
Reporter assays were conducted 6 hr post-BDNF stimulation. Lucifer-
ase activity was measured as previously described (Matthews et al.,
1994) and normalized to b-galactosidase activity (Impey et al., 1996).
Figure 8. Model for Role of SCOP in MAPK Activation
It is hypothesized that SCOP attenuates MAPK activity in hippocampal
neurons by binding to the nucleotide-free form of K-Ras, thereby inhib-
iting stimulation of the MAPK pathway. Calpain may contribute to ERK
activation by degrading SCOP.
Immunohistochemistry
Animals were deeply anesthetized with Ketamine/Xylazine cocktail
and intracardially perfused with saline containing 0.1% NaNO2 and
2.0 mM EDTA. They were then continuously perfused with ice-cold
2% paraformaldehyde in PBS. Brains were removed, postfixed for
3 hr, and dehydrated in 30% sucrose in PBS overnight. The dehy-
drated brains were frozen in dry ice and sliced into 25-mm-thick sec-
tions using a microtome. Sections were washed three times with
0.5% Triton X-100 in PBS and incubated in 0.5% Triton X-100, 0.5%
BSA, and 1% normal goat serum for 30 min at 37C. They were then
incubated with anti-SCOP antibody (aEC) (1:50) overnight at 4C (Shi-
mizu et al., 1999). Immunoreactivity was detected by the conventional
avidin-biotin complex method (Vectastain ABC Kit; Vector Lab) using
3-30 diaminobenzidine as chromogen. Brain sections were mounted
using DPX mountant (Fluka).
Immunoprecipitation of SCOP
Whole brains from adult male mice were homogenized in 10-fold
excess (v/v) of buffer A (50 mM Tris-HCl, pH.7.4, 50 mM NaCl, 1 mM
EDTA). The resulting homogenate was centrifuged at 10,000 3 g for
15 min. The supernatant was used for immunoprecipitation and pre-
cleared on protein A agarose beads (Oncogene) at 4C for 2 hr incuba-
tion on a rotating wheel. The precleared cell lysate was incubated over-
night at 4C with a C-terminal SCOP antibody (Shimizu et al., 1999).
New protein agarose beads were added and incubated for 2 hr at
4C. The beads were washed four times with buffer A.
Western Analysis
Mice were sacrificed by cervical dislocation and the hippocampi were
rapidly dissected and immediately frozen in dry ice. Two hippocampi
were sonicated for 10 s in the sonication buffer (20 mM Tris-HCl,
150 mM NaCl, 1% NP-40, 2 mM EDTA, 5 mM EGTA, 5 mM b-mercap-
toethanol, 50 mM NaF, 1 mM Na3VO4, 1 mM phenylmethanesulfonyl
fluoride, pH 7.4) with a protease inhibitor cocktail (complete mini,
EDTA-free, Roche) and phosphatase inhibitor cocktail I and II (Sigma).
Neurons from 3 cm culture dishes were treated with 150 ml of 23 SDS
sample buffer and cells were scraped from the dish. The resulting
homogenates were treated with SDS sample buffer, boiled for 3 min,
and subjected to SDS-PAGE and western analysis.
Housing and Handling of Mice
Male C57BL6 mice at 8–11 weeks of age were used. Food and water
were provided ad libitum, and animals were kept on a 12 hr light/dark
cycle. To reduce handling-induced stress, mice were housed individ-
ually and handled daily for one week prior to experiments.
Behavioral Assays
Context-trained mice were placed into a conditioning chamber (Solid
State Shocker/Distributor; Coulbourn Instruments, Allentown, PA)
and allowed to explore. After 2 min, they were shocked one time
(0.7 mA, 2 s). Mice were then allowed to recover for 1 min and returned
to home cages. Unpaired controls were shocked once for 2 s immedi-
ately after being placed in context. Novel object-trained mice were first
habituated in a training rat cage for 3–4 hr before training. After this,
two different objects A and B were presented for 5 min, after which
they were returned to their home cage. They were tested in the training
cage with a new object C and one of the original objects A or B. During
training and testing, the time spent examining each object was re-
corded for 5 min. Memory for familiar objects is manifested as a prefer-
ence for the new object C during testing. Control mice were placed
into the training cage with no novel objects.
Cannulation and Calpain Inhibitor Infusion
Mice (8 weeks old) were cannulated as described previously (Athos
et al., 2002). Briefly, mice were anesthetized with an intraperitonial in-
jection (20 ml/g body weight) of a mixture of ketamine (7.0 mg/ml) and
xylazine (0.44 mg/ml) dissolved in bacteriostatic saline. AnesthetizedCmice were mounted on a stereotaxic frame (10 micron model, Carte-
sian Research), and 30-gauge dummy cannulae were implanted just
above the pyramidal cell layer of CA1 region of dorsal hippocampus.
Cannulae resided 1.5 mm lateral, 1.25 mm ventral, and 1.5 mm poste-
rior from bregma. The cannulae were affixed with dental acrylic and fit-
ted with 24-gauge guide cannulae to maintain cannula position. Mice
were housed individually and allowed at least 1 week of postoperative
recovery before handling. Calpain inhibitor I, calpain inhibitor III, and
calpeptin were dissolved in DMSO and further diluted in 10% Cremo-
phor EL (SIGMA) in saline so that the final concentrations of inhibitors
were 2 mM each. Drug and vehicle solutions had a final concentration
of 18% DMSO and 8.2% Cremophor EL. One-half microliters of drug
or vehicle was infused bilaterally into the cannulae through a 30-gauge
injection needle 45 min before object recognition training. The final
concentrations of the inhibitors in the hippocampus were 20 mM. The
infusions were carried out at a rate of 0.25 ml/min using a motorized
syringe pump (kdScientific).
Generation of Tet-on SCOP Overexpression Mouse
Complementary DNA encoding rat SCOP was inserted into the multi-
cloning site of pTRE2 (BD Biosciences) so that the expression of SCOP
was placed under the control of Tet-responsive promoter (TRE). A
TRE-SCOP-poly A cassette from the subcloned plasmid was injected
(pronuclear) into C57BL6/C3H X C57BL6 embryos. The genotype was
determined by PCR using transgene-specific primers. Transgenic
mice were bred into the C57BL6 background for at least six genera-
tions. Manipulations were approved and in accordance with the animal
care committee’s guidelines at the University of Washington.
SCOP Overexpression in the Forebrain
CamKIIa promoter-rtTA2 (CamKII-rtTA2) mouse was generously pro-
vided by Dr. Isabelle Mansuy’s laboratory at the Swiss Federal Institute
of Technology. CamKII-rtTA2 mice were mated with TRE-SCOP mice
to obtain double transgenic mice, which allowed SCOP overexpres-
sion in the forebrain to be mice controlled by tetracycline. Genotyping
was determined by PCR. Control mice were littermates carrying no
transgene or either one of the transgenes. Before testing, mice were
fed doxycycline (SIGMA) at 6 mg per g food, as indicated. For all exper-
iments, we used male mice 2–5 months old for behavioral studies.
Supplemental Data
Supplemental Data include five figures and can be found with this
article online at http://www.cell.com/cgi/content/full/128/6/1219/
DC1/.
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